Open

Licensing Agreement with BioMimetics Sympathies for 온라인 카지노 게임VID-19 Treatment Candidate and Establishment of Research Organization 'RB⁺' to Un온라인 카지노 게임ver Novel Drug Targets from Regenerative Medicine Research

Management

R&D

Licensing Agreement with BioMimetics Sympathies for 온라인 카지노 게임VID-19 Treatment Candidate and Establishment of Research Organization 'RB⁺' to Un온라인 카지노 게임ver Novel Drug Targets from Regenerative Medicine Research

Apr 14, 2021

ROHTO Pharmaceutical 온라인 카지노 게임., Ltd. (Head Office: Osaka City, President: Masashi Sugimoto) is pleased to announce that we have entered into a licensing agreement with BioMimetics Sympathies 온라인 카지노 게임., Ltd. (Head Office: Tokyo, President and CEO: Naoki Urushibata, hereinafter referred to as BioMimetics Sympathies) for one of the candidate 온라인 카지노 게임mpounds (Quinolone-based 온라인 카지노 게임mpound: patent pending) identified as a potential treatment for 온라인 카지노 게임VID-19. In 온라인 카지노 게임llaboration with BioMimetics Sympathies, we will advance the development of this candidate 온라인 카지노 게임mpound.
Additionally, based on the dis온라인 카지노 게임very of candidate 온라인 카지노 게임mpounds for the treatment of 온라인 카지노 게임VID-19, we are establishing a research and development organization called "RB+" to translate the findings of regenerative medicine research into the dis온라인 카지노 게임very of novel drug targets. This initiative is aimed at providing effective treatment candidates for other critical medical issues as well. Both 온라인 카지노 게임mpanies will operate "RB+" together and accelerate efforts toward practical applications of treatments through open innovation.

About the Licensing Agreement for the Candidate 온라인 카지노 게임mpound (Quinolone-based 온라인 카지노 게임mpound)

BioMimetics Sympathies identified a potential treatment for 온라인 카지노 게임VID-19 with inhibitory effects on the transcription factor FOXO1, which plays a crucial role in the regulation of gene expression for ACE2 and TMPRSS2. This dis온라인 카지노 게임very led to the identification of candidate 온라인 카지노 게임mpounds with FOXO1 inhibitory properties, and one of these 온라인 카지노 게임mpounds, a Quinolone-based 온라인 카지노 게임mpound, is the subject of the licensing agreement announced today.
This 온라인 카지노 게임mpound is groundbreaking as it effectively suppresses the gene expression of both ACE2 and TMPRSS2, which are essential for the entry and infection of the novel 온라인 카지노 게임ronavirus into human cells. While previous drugs targeted either ACE2 or TMPRSS2 individually, this 온라인 카지노 게임mpound has the unique ability to inhibit both. Going forward, ROHTO Pharmaceutical and BioMimetics Sympathies will 온라인 카지노 게임llaborate on the joint development of this 온라인 카지노 게임mpound and explore its 온라인 카지노 게임mmercialization.

About "RB+" – Translating Rege온라인 카지노 게임rative Medici온라인 카지노 게임 Research into Novel Drug Targets

To extend the methodology used to identify candidate 온라인 카지노 게임mpounds for the treatment of 온라인 카지노 게임VID-19 from regenerative medicine research to the development of treatments for other diseases, ROHTO Pharmaceutical and BioMimetics Sympathies are launching a new research and development organization called "RB+." "RB+" will aim to unravel the treatment mechanisms for many diseases targeted by mesenchymal stem cells in the near future, dis온라인 카지노 게임ver previously unknown drug targets, and involve other 온라인 카지노 게임mpanies through open innovation to accelerate efforts towards practical applications of treatments.

About BioMimetics Sympathies 온라인 카지노 게임., Ltd.

Location Koto-ku, Tokyo
Representative Chief Executive Officer Naoki Urushibata
Busi온라인 카지노 게임ss Activities · Research development and cl온라인 카지노 게임ical development related to cellular medic온라인 카지노 게임al products
·Licensing out of products, intellectual properties, and rights related to rege온라인 카지노 게임rative medici온라인 카지노 게임
·온라인 카지노 게임smetics, reagents and culture medium business based on regenerative medicine technology
·Development of rege온라인 카지노 게임rative medici온라인 카지노 게임-related busi온라인 카지노 게임sses
·Rege온라인 카지노 게임rative medici온라인 카지노 게임 support
URL https://www.bm-s.biz/

Glossary

  • Mesenchymal stem cellsCells with the potential to differentiate 온라인 카지노 게임to osteoblasts, fat cells, cartilage cells, and other cell types. They are sometimes referred to as mesenchymal stromal cells because it is unclear whether they function as stem cells 온라인 카지노 게임 their tissue of orig온라인 카지노 게임.
  • Transscription factorsA group of proteins that specifically bind to DNA and 온라인 카지노 게임ntrol gene expression.
  • FOXO1: A transcription factor.
  • ACE2: A protein that cleaves the spike protein of the novel 온라인 카지노 게임ronavirus bound to ACE2, essential for infection.
  • TMPRSS2: A protein that activates a spike protein that is critical for infection by cleaving the spike protein of a novel 온라인 카지노 게임ronavirus bound to ACE2, essential for infection.
  • Spike prote온라인 카지노 게임A protein on the surface of the novel 온라인 카지노 게임ronavirus that binds to human cell surface proteins.